eXIthera is the leader in Factor XIa inhibition, the ideal target for anticoagulation, preventing thrombosis without an increased risk in bleeding.
eXIthera’s drug candidates are small molecules that are highly potent and selective Factor XIa inhibitors. Factor XIa is a key player in the thrombosis pathway but is not required for normal hemostasis.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.